[Pathological diagnosis of Danon disease by endomyocardial biopsy]
1Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Insights
Danon disease, a rare genetic disorder, causes hypertrophic cardiomyopathy due to lysosome-associated membrane protein-2 (LAMP2) gene mutations. Key features include vacuolar degeneration and glycogen accumulation in heart cells, aiding differential diagnosis.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Danon disease is a rare genetic disorder.
- It is characterized by hypertrophic cardiomyopathy.
Purpose of the Study:
- To investigate the clinicopathological features of Danon disease.
- To aid in the differential diagnosis of Danon disease.
Main Methods:
- Analysis of two male patients diagnosed with Danon disease.
- Inclusion of clinical history, histological, immunohistochemical, ultrastructural, and genetic mutation analysis.
- Identification of lysosome-associated membrane protein-2 (LAMP2) gene mutations.
Main Results:
- Patients presented with hypertrophic cardiomyopathy.
- Histological findings included cardiomyocyte hypertrophy and vacuolar degeneration.
- Ultrastructural analysis revealed glycogen accumulation; LAMP2 gene mutations were identified.
Conclusions:
- Danon disease is a rare cause of hypertrophic cardiomyopathy.
- Mutations in the LAMP2 gene are the underlying cause.
- Clinicopathological features, including vacuolar degeneration and glycogen accumulation, are critical for diagnosis and avoiding misdiagnosis.
Abstract:
Objective To investigate the clinicopathological features and differential diagnosis of Danon disease. Methods: Two cases of Danon disease were selected from Beijing Anzhen Hospital Affiliated to Capital Medical University from January 2019 to December 2019. The clinical history, histological, immunohistochemical, ultrastructural and gene mutation analysis were collected. Results: Both of the patients were male, aged 21 and 19 years old, respectively. They were diagnosed with hypertrophic cardiomyopathy by clinicians. The histologic features of endocardial biopsies were hypertrophy and vacuolar degeneration of cardiomyocytes. Part of cardiomyocytes appeared as intracellular clear areas lacking myofibers. The nuclei were large, irregular and hyperchromatic. And lipofuscin was occasionally observed in the nuclei of cardiomyocytes. Ultrastructural feature of electron microscopic was glycogen accumulation. Genetic analysis identified two lysosome-associated membrane protein-2 (LAMP2) gene mutations. A 1-bp deletion in exon 8 (c.973delC) was found in patient 1, leading to a frame-shift mutation. A 3-bp duplication in exon 5 (c.719_721dupAGC) was found in patient 2, leading to an insertion mutation. Conclusions: Danon disease is a rare disease characterized by hypertrophic cardiomyopathy. It is caused by mutations in the LAMP2 gene. Vacuolar degeneration of cardiomyocytes, glycogen accumulation under electron microscope and the mutation of LAMP2 gene are the critical features of Danon disease. Familiar with its clinicopathological characteristics would be helpful to avoid the misdiagnosis of Danon disease.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification


